Recursion Pharmaceuticals, Inc. RXRX Increase (Decrease) in Other Operating Assets
Increase (Decrease) in Other Operating Assets at other companies
Other financials
Where this comes from
Reported directly by Recursion Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherOperatingAssets.
The official record: Recursion Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Recursion Pharmaceuticals, Inc.'s increase (decrease) in other operating assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Recursion Pharmaceuticals, Inc.'s increase (decrease) in other operating assets?
- Recursion Pharmaceuticals, Inc. (RXRX) reported increase (decrease) in other operating assets of -$14.75M in Q1 2026.
- How has Recursion Pharmaceuticals, Inc.'s increase (decrease) in other operating assets changed year-over-year?
- Recursion Pharmaceuticals, Inc.'s increase (decrease) in other operating assets decreased by 204.7% year-over-year, from -$4.84M to -$14.75M.
- What does increase (decrease) in other operating assets mean?
- This captures the net change in miscellaneous assets that are not classified as loans, securities, or property, plant, and equipment. It often includes items like accrued interest receivables, prepaid expenses, and other short-term operational assets.